These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16462712)

  • 1. Prevalence of diabetes mellitus and impaired glucose tolerance in beta-thalassemia patients with and without hepatitis C virus infection.
    Mowla A; Karimi M; Afrasiabi A; De Sanctis V
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():282-4. PubMed ID: 16462712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes mellitus and impaired glucose tolerance in thalassaemia major: incidence, prevalence, risk factors and survival in patients followed in the Ferrara Center.
    Gamberini MR; Fortini M; De Sanctis V; Gilli G; Testa MR
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():285-91. PubMed ID: 16462713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virological, immunological and histological aspects in adult beta-thalassemic patients with chronic hepatitis C virus infection.
    Siagris D; Giannakoulas N; Christofidou M; Tsamandas A; Lekkou A; Thomopoulos K; Zoumbos N; Labropoulou-Karatza Ch
    Liver Int; 2004 Jun; 24(3):204-9. PubMed ID: 15189270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reappraisal of the characteristics of glucose abnormalities in patients with chronic hepatitis C infection.
    Huang JF; Yu ML; Dai CY; Hsieh MY; Hwang SJ; Hsiao PJ; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Shin SJ; Chang WY; Chuang WL
    Am J Gastroenterol; 2008 Aug; 103(8):1933-40. PubMed ID: 18637090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of diabetes mellitus and chronic hepatitis C virus infection.
    Mason AL; Lau JY; Hoang N; Qian K; Alexander GJ; Xu L; Guo L; Jacob S; Regenstein FG; Zimmerman R; Everhart JE; Wasserfall C; Maclaren NK; Perrillo RP
    Hepatology; 1999 Feb; 29(2):328-33. PubMed ID: 9918906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCV and HGV infection, iron overload and liver disease in multitransfused patients with thalassaemia and persistently normal or abnormal transaminase levels.
    Gamberini MR; Francesconi R; Fortini M; Cavazzini L; Lari F; Scapoli C; Ballardini G; De Sanctis V; Bianchi FB
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():259-66. PubMed ID: 16462707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.
    Khalifa AS; Salem M; Mounir E; El-Tawil MM; El-Sawy M; Abd Al-Aziz MM
    Pediatr Diabetes; 2004 Sep; 5(3):126-32. PubMed ID: 15450007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia.
    Kattamis C; Ladis V; Tsoussis D; Kaloumenou I; Theodoridis C
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():267-71. PubMed ID: 16462709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of serum insulin-like growth factor-1 (IGF-1) levels with hepatitis C virus infection and insulin resistance.
    Helaly GF; Hussein NG; Refai W; Ibrahim M
    Transl Res; 2011 Sep; 158(3):155-62. PubMed ID: 21867981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of endocrine complications and short stature in patients with thalassaemia major: a multicenter study by the Thalassaemia International Federation (TIF).
    De Sanctis V; Eleftheriou A; Malaventura C;
    Pediatr Endocrinol Rev; 2004 Dec; 2 Suppl 2():249-55. PubMed ID: 16462705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.
    Gamberini MR; Fortini M; Gilli G; Testa MR; De Sanctis V
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():867-9. PubMed ID: 10091159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of hepatitis C virus genotypes in beta-thalassaemic patients from Northern India.
    Chakravarti A; Verma V
    Transfus Med; 2006 Dec; 16(6):433-8. PubMed ID: 17163874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergic effect of chronic hepatitis C infection and beta thalassemia major with marked hepatic iron overload on liver fibrosis: a retrospective cross-sectional study.
    Ardalan FA; Osquei MR; Toosi MN; Irvanloo G
    BMC Gastroenterol; 2004 Aug; 4():17. PubMed ID: 15307893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study.
    Mavrogiannaki A; Karamanos B; Manesis EK; Papatheodoridis GV; Koskinas J; Archimandritis AJ
    J Viral Hepat; 2009 Jun; 16(6):430-6. PubMed ID: 19200136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes pattern on the 75 g oral glucose tolerance test is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus.
    Konishi I; Hiasa Y; Shigematsu S; Hirooka M; Furukawa S; Abe M; Matsuura B; Michitaka K; Horiike N; Onji M
    Liver Int; 2009 Sep; 29(8):1194-201. PubMed ID: 19422477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis.
    Custro N; Carroccio A; Ganci A; Scafidi V; Campagna P; Di Prima L; Montalto G
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):476-81. PubMed ID: 11547221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus.
    Arao M; Murase K; Kusakabe A; Yoshioka K; Fukuzawa Y; Ishikawa T; Tagaya T; Yamanouchi K; Ichimiya H; Sameshima Y; Kakumu S
    J Gastroenterol; 2003; 38(4):355-60. PubMed ID: 12743775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients.
    Imazeki F; Yokosuka O; Fukai K; Kanda T; Kojima H; Saisho H
    Liver Int; 2008 Mar; 28(3):355-62. PubMed ID: 18290778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiphospholipid antibodies and hepatitis C virus infection in Iranian thalassemia major patients.
    Kashef S; Karimi M; Amirghofran Z; Ayatollahi M; Pasalar M; Ghaedian MM; Kashef MA
    Int J Lab Hematol; 2008 Feb; 30(1):11-6. PubMed ID: 18190462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
    Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
    J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.